Table 3 Univariate analyses of various clinical parameters in prostate cancer patients

Age (years)

0.958 (0.938–0.981)

<0.001

0.993 (0.962–1.024)

0.641

1.005 (0.975–1.035)

0.749

PSA (μg/L)

1.003 (1.002–1.004)

<0.001

1.003 (1.001–1.005)

0.002

1.002 (1.000–1.004)

0.029

Gleason Score

<0.001

<0.001

<0.001

 ≤ 7

1

1

1

 > 7

2.791 (1.921–4.055)

4.710 (2.499–8.878)

4.998 (2.286–6.993)

Metastasis

<0.001

<0.001

<0.001

 No

1

1

1

 Yes

3.447 (2.385–4.984)

5.893 (3.128–11.102)

3.951 (2.331–6.696)

Risk Stratification

0.005

0.058

0.111

 Lowintermediate

1

1

1

 High

4.128 (1.524–11.182)

6.751 (0.935–48.730)

2.560 (0.805–8.140)

Platelet (10⁹/L)

0.053

0.157

0.121

 < 190.50

1

1

1

 ≥ 190.50

1.414 (0.995–2.003)

1.442 (0.869–2.394)

1.450 (0.907–2.318)

Lymphocyte (10⁹/L)

0.866 (0.632–1.185)

0.367

0.724 (0.454–1.153)

0.174

0.775 (0.506–1.188)

0.242

PLR

0.029

0.014

0.020

 < 117.58

1

1

1

 ≥ 117.58

1.480 (1.040–2.107)

1.948 (1.145–3.312)

1.781 (1.096–2.894)